The materials presented here share a common theme: the early recognition of risk and the need to respond to warning signs before a problem develops into a crisis. In one case, the issue is international law, which should prevent war crimes before they destroy the rule of law; in the other two, it is breast cancer, where artificial intelligence and close attention to skin changes may accelerate detection. At the same time, all the sources emphasize that an early signal is important but is not, by itself, a final diagnosis or decision. It should trigger further checks, professional discussion, and subsequent action.
In The Independent article, this idea is expressed at the level of international politics. The Nobel Peace Prize was awarded to former UN High Commissioner for Human Rights Navi Pillay for her contribution to ensuring that “war crimes, crimes against humanity and genocide are prosecuted.” Jørgen Watne Frydnes, chair of the Norwegian Nobel Committee, linked the decision to a period in which “the international legal system is under enormous pressure and its institutions are under attack.”
Pillay, a South African lawyer and judge, defended Nelson Mandela and other opponents of apartheid, served as a judge on the International Criminal Tribunal for Rwanda, and led an independent UN commission that concluded Israel was committing genocide in Gaza. Israel rejects the accusation. The award therefore represented not only recognition of Pillay’s career but also a public defense of the principle that serious crimes should be addressed through legal procedures rather than determined solely by political power.
The political contrast was heightened by her joke directed at Donald Trump. At a conference in Nuremberg, Pillay said: “If you applaud a little more, perhaps I will share this prize with Trump.” The US president has long sought the Nobel Peace Prize and claims to have “settled eight wars.” In the past, the White House sharply criticized the committee when the award went to Venezuelan opposition leader María Corina Machado, accusing the organizers of putting “politics above peace.”
The committee’s central message was stated in particularly direct terms: “Whenever force prevails over law, it undermines stability, trust and peaceful coexistence.” In this context, international law refers to the body of treaties, norms and judicial mechanisms designed to constrain the actions of states and individuals, including during conflicts. Its purpose is not only to punish those responsible after the fact but also to create a deterrent effect: to show that aggression, torture, mass killings and the persecution of civilians must not go without consequences.
Medical publications demonstrate a similar logic at the individual level. A Fox News article describes an artificial intelligence study that assesses the likelihood of developing breast cancer within five years. The model analyzes not only the most recent scan but also several years of 3D mammograms, tracking gradual changes in breast tissue. The training data included more than 313,000 mammograms from over 161,000 women.
This represents an important distinction from traditional diagnosis. A standard mammogram primarily answers the question of whether cancer is visible now. The algorithm additionally attempts to assess future risk by identifying subtle patterns that may not be visible to the human eye. As breast-imaging specialist Conny Lehman noted, “A mammogram can tell you more than just whether cancer is visible today—it can also provide information about the risk of developing cancer in the years ahead.”
The potential benefit of this approach lies in more individualized screening. Women at elevated risk may be offered additional testing, such as an MRI, while patients at average risk may continue with standard mammograms. At the same time, analyzing existing scans would not necessarily require additional radiation exposure.
However, the authors and experts emphasize the technology’s limitations. A high risk score does not mean that a woman already has cancer or that she will definitely develop it. A low score does not eliminate the need for regular mammograms. The model remains a research tool and has not received FDA approval for clinical use. In addition, the data came from NYU Langone facilities and were associated with equipment from a single manufacturer. Research at other medical centers and with different types of systems is needed to determine whether the algorithm is broadly applicable.
In an ABC News report, early detection is considered through a different, more accessible signal: changes in the skin. Breast cancer does not always begin with a lump. According to the data cited, up to 10% of patients initially sought medical attention because of skin-related symptoms. Possible signs include changes in color, a persistent rash, swelling, a feeling of warmth, thickening or dimpling of the skin resembling an orange peel, and an inverted nipple.
Inflammatory breast cancer requires particular attention. It is a rare but aggressive form, accounting for approximately 1–5% of all cases. It often does not produce a distinct tumor and may not be detected on a mammogram. As a result, it can sometimes be mistaken for an infection or eczema. If antibiotics do not help, a doctor may order a core-needle or punch biopsy, a procedure in which a small sample of skin or tissue is taken for microscopic examination. This illustrates how persistent attention to an ongoing symptom can help move from an initial assumption to a confirmed diagnosis.
ABC News also describes symptoms that can arise during treatment. Radiation therapy may cause redness, itching, swelling, darkening of the skin and peeling. Chemotherapy can lead to hair loss, including the eyelashes and eyebrows. For many patients, this is not merely a cosmetic concern. As oncologist Elizabeth Comen says, “Hair loss is not a superficial thing. It can be a huge part of one’s identity.”
Support options include gentle skin care, moisturizers, topical medications and, in appropriate cases, scalp cooling during chemotherapy. According to data cited by ABC News, up to two-thirds of women who use a cold cap retain at least half of their hair. However, effectiveness depends on the treatment regimen, so any additional procedures should be discussed with an oncologist.
All three texts reflect a common principle: complex systems must be able to detect gradual changes and must not wait for an obvious catastrophe. In international politics, such “signals” include attacks on independent institutions, the rejection of legal procedures and the replacement of law with force. In medicine, they include subtle changes on sequential scans or persistent skin changes that may not fit the usual expectations associated with a disease.
At the same time, an early warning is not the same as a final conclusion. The Nobel Peace Prize does not end wars or guarantee compliance with international law; it simply draws greater attention to its principles. A risk-assessment algorithm does not diagnose cancer; it helps identify who may need closer monitoring. A skin rash does not necessarily indicate a tumor, but a new or persistent change requires medical evaluation.
The key conclusion is that prevention is becoming increasingly personalized and interdisciplinary. In healthcare, radiologists, oncologists, dermatologists and data specialists may work together to assess risk, symptoms and treatment side effects. In the international sphere, the resilience of peace depends on judges, investigators, human rights advocates and institutions capable of acting independently of pressure from powerful states.
These materials also demonstrate the limits of technology and public statements. Artificial intelligence can identify patterns, but it requires validation using diverse data and oversight by specialists. Medical information in the media can raise awareness, but it does not replace consultation with a doctor. The Nobel Prize can draw attention to a crisis in international law, but its symbolic authority cannot replace judicial mechanisms.
Thus, the common theme of these sources is the transformation of an early signal into responsible action. In medicine, this may mean additional testing or a biopsy; in international law, it may mean an investigation and prosecution. The earlier a system recognizes risk—and the more reliably it distinguishes a warning from a hasty conclusion—the greater the likelihood of preventing serious consequences.
